Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03774836Phase 3Active, not recruiting
Phase 3, randomised, double-blind trial of tramadol in postoperative pain (3 arms), sponsored by Avenue Therapeutics. Primary endpoint: Sum of Pain Intensity Differences through 24 hours. Started Dec 2018; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03774836.